Real-Life 2-Year Therapeutic Strategies in the Management of 525 Small-Cell Lung Cancers: The ESCAP Study Preliminary Results

被引：0
|
作者：
Debieuvre, Didier [1 ]
Goupil, Francois [2 ]
Brun, Philippe [3 ]
Dixmier, Adrien [4 ]
De Faverges, Geoffroy [5 ]
Nocent-Ejnaini, Cecilia [6 ]
Crequit, Jacky [7 ]
Vuillermoz-Blas, Sylvie [8 ]
Perrin, Christophe [9 ]
Leleu, Olivier [10 ]
Carbonnelle, Michel [11 ]
Goutorbe, Frederic [12 ]
Asselain, Bernard [13 ]
Blanchon, Francois [14 ]
Martin, Francis [15 ]
Grivaux, Michel [14 ]
机构：
[1] Emile Muller Gen Hosp, Mulhouse, France
[2] Ctr Hosp Mans, Le Mans, France
[3] Ctr Hosp Gen Valence, Valence, France
[4] Ctr Hosp Orleans, Orleans, France
[5] Hop Pierre Beregovoy, Nevers, France
[6] Ctr Hosp Cote Basque, Bayonne, France
[7] Ctr Hosp Laennec, Creil, France
[8] Ctr Hosp St Joseph St Luc, Lyon, France
[9] Ctr Hosp Cannes, Cannes, France
[10] Ctr Hosp Abbeville, Abbeville, France
[11] Hop Auban Moet, Epernay, France
[12] Ctr Hosp Gen Beziers, Beziers, France
[13] Inst Curie, Paris, France
[14] Ctr Hosp Meaux, Meaux, France
[15] Ctr Hosp Gen Compiegne, Compiegne, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
therapeutic strategies; small-cell lung cancers;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-013
引用
收藏
页码：S500 / S500
页数：1
相关论文
共 50 条
  • [41] MORTALITY AND MORBIDITY IN 2-YEAR DISEASE-FREE SURVIVORS OF SMALL-CELL LUNG-CANCER AFTER TREATMENT WITH COMBINATION CHEMOTHERAPY WITH OR WITHOUT IRRADIATION
    OHNOSHI, T
    HIRAKI, S
    FUJII, M
    UEOKA, H
    YONEI, T
    TAMURA, M
    MORITAKA, T
    MIMA, Y
    HORIGUCHI, T
    KIURA, K
    KAMEI, H
    KODANI, T
    HIRAKI, Y
    KIMURA, I
    ACTA MEDICA OKAYAMA, 1993, 47 (03) : 209 - 214
  • [42] Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation
    Kawahara, M
    Ushijima, S
    Kamimori, T
    Kodama, N
    Ogawara, M
    Matsui, K
    Masuda, N
    Takada, M
    Sobue, T
    Furuse, K
    BRITISH JOURNAL OF CANCER, 1998, 78 (03) : 409 - 412
  • [43] SMALL-CELL LUNG-CANCER - RESULTS OF A PHASE-II STUDY OF 1,2,4 TRIGLYCIDYLURAZOL
    CUNNINGHAM, D
    BANHAM, SW
    SOUKOP, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 17 (01) : 85 - 86
  • [44] Treating grass pollen allergic patients with severe allergic rhinoconjunctivitis symptoms with 5-grass pollen tablets results from a 2-year real-life medical practice study
    Karagiannis, E.
    Hadler, M.
    Shah-Hosseini, K.
    Moesges, R.
    ALLERGY, 2014, 69 : 413 - 413
  • [45] Comparison of oral versus intravenous etoposide in the management of small-cell lung cancer; A real-world, population-based study
    Karachiwala, Hatim
    Tilley, Derek
    Abdel-Rahman, Omar
    Morris, Don
    CLINICAL RESPIRATORY JOURNAL, 2021, 15 (01): : 36 - 41
  • [46] Changes in choroidal thickness after anti-vascular endothelial growth factor treatment of diabetic macular edema, real-life data, 2-year results
    Savur, Fatma
    Kaldirim, Havva
    Atalay, Kursat
    Korkmaz, Safak
    CUTANEOUS AND OCULAR TOXICOLOGY, 2021, 40 (04) : 326 - 331
  • [47] Real-Life Study of Patients with Unresectable Stage III Non-Small Cell Lung Cancer Treated with Chemoradiotherapy Followed by Durvalumab
    Tuller, M.
    Buela, G.
    Ferreira, Y.
    Antivero, A.
    Lupinacci, L.
    Basbus, L.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S607 - S608
  • [48] Evaluation of Real-Life Chemoimmunotherapy Combination in Patients with Metastatic Small Cell Lung Carcinoma (SCLC): A Multicentric Case-Control Study
    Ezzedine, Remy
    Canellas, Anthony
    Naltet, Charles
    Wislez, Marie
    Azarian, Reza
    Seferian, Andrei
    Leprieur, Etienne Giroux
    CANCERS, 2023, 15 (18)
  • [49] Real-life effectiveness of erlotinib as second-line treatment of stage IIIB/IV squamous non-small cell lung cancer: Results of the PEPiTA observational study
    Monnet, Isabelle
    Audigier-Valette, Clarisse
    Girard, Nicolas
    Vergnenegre, Alain
    Molinier, Olivier
    Souquet, Pierre Jean
    Blanchon, Francois
    Bonnetain, Franck
    Taguieva-Pioger, Naila
    Lamour, Corinne
    Wislez, Marie
    LUNG CANCER, 2016, 98 : 84 - 90
  • [50] Health-related quality of life (HRQoL) of non-small cell lung cancer (NSCLC) patients treated with nivolumab in real-life: The EVIDENS study
    Perol, M.
    Dixmier, A.
    Barlesi, F.
    Debieuvre, D.
    Raspaud, C.
    Auliac, J. B.
    Benoit, N.
    Bombaron, P.
    Moro-Sibilot, D.
    Asselain, B.
    Cotte, F-E.
    Lamoureux, P.
    Karam, N.
    Ozan, N.
    Calvet, C.
    Bryan, B.
    Allan, V.
    Valette, C. Audigier
    ANNALS OF ONCOLOGY, 2019, 30 : 46 - 46
12345